Euro-Sante :: Euro-Health

Archives for Innovation and Growth

A central feature of any high performing healthcare system or organisation includes best practice in medicines use and management. As all aspects of healthcare are under varying degrees of financial stress these days, cost controls and appropriate use of medicines must support the highest standards of clinical practice and safe patient care. Medicines optimisation is… » read more

Posted by EuroSante

It is in the interests of the Commission to play countries off against each other in order to demonstrate the inescapable logic of the “European project”. The Commission suffers from the so-called “secretariat problem”: it is not a member state but a “secretariat” for the member states, and in this way pursues its own interests… » read more

Posted by EuroSante

Continuing with my thoughts today on excess costs (last post was on medicines waste), I thought I think about excess hospitalisation, another type of waste. Excess risk of hospitalisation is calculated as the difference between observed hospitalisation (for a condition) and expected population rates. What are the determinants of excess hospitalisation? Excess hospitalisation can be… » read more

Posted by EuroSante

Just about every country has identified life sciences in some form or other as a priority for academic and commercial development. But what will characterise the countries that may in the end prevail? The research community needs a high degree of autonomy. The European University Association released an interesting study, University Autonomy in Europe II:… » read more

Posted by EuroSante

There is a clutch of small states within the European Union. There are many more small states outside the EU. Much can be learned from them, as at least within the EU, some seem more robustly managed and economic productive than their larger debt-laden counterparts. Healthcare systems are often seen as requiring some degree of… » read more

Posted by EuroSante